PATENT CLAIM ANALYSIS

Application Number: 16120837
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2018-12
Patent Classification: ["544", "355000"]

Abstract:
The invention relates to Substituted-Quinoxaline-Type Bridged-Piperidine Compounds, compositions comprising an effective amount of a Substituted-Quinoxaline-Type Bridged-Piperidine Compound and methods to treat or prevent a condition, such as pain, comprising administering to an animal in need thereof an effective amount of a Substituted-Quinoxaline-Type Bridged-Piperidine Compound.

Claim (Index 68):
The method of  claim 64 , wherein said process comprises a reaction of converting the compound of formula QB to a compound of formula QB2:

Metadata:
- Claim Count in Document: 149.0
- Percentile: 97.0
- Lexical Diversity: 1.54839
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13010632', '13915204', '14859139', '13996440', '13952284']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7697118114878588
- 35 USC 102 Novelty (BERT): 0.5361205919590784
- Combined Prediction Score: 0.7463526895349808
- Mean Citation Score: 313.28399
- Max Citation Score: 323.89944
- Similarity Product: 139.86133485077622

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test